Copy
LISAvienna e-Newsletter 02/2016 – Get Connected
Is this email not displaying correctly?
View it in your browser


 

e-Newsletter 02/2016

Dear readers,

It’s time to take a break and appreciate some success stories from Vienna again. Academic and commercial life sciences blossom like flowers in spring in our wonderful city!
 
Are you watching out for new capital sources? Profit from screening our overview on opportunities for support and private equity partners and join us on delegation trips and trade fairs!
 
Happy Easter!
LISAvienna

NEWSFLASH

AIT: Elke Guenther to head AIT Health & Environment Department
As of June 2016, Elke Guenther will take over the management of AIT’s Health & Environment Department. She is a biologist by training and has been recruited from the University of Tübingen and NMI TT GmbH where Guenther isin charge of the pharma services department.
APEPTICO’s development compounds Solnatide has been granted Orphan Drug Designation for two indications by the FDA
FDA has granted Orphan Drug Designation to Solnatide for the “Treatment of Primary Graft Dysfunction following Lung Transplantation” and for the “Treatment of Pseudohypoaldosteronism Type 1B” a few weeks after the positive decision by the European Medicines Agency.
Arsanis appoints Michael P. Gray as Chief Financial Officer and Chief Business Officer
Gray comes to Arsanis from Curis, Inc. where he held a variety of managementpositions over the past 15 years. At Arsanis he will lead financial strategy, planning and operations as well as corporate and business development
Biomay initiates new phase II clinical trial with grass pollen allergy vaccine BM32
The aim of the study is the optimization of the dose regimen of BM32 to achieve optimal allergen specific blocking immune response in grass pollen allergy patients and thereby maximized protection from allergic symptoms during the pollen season.
Diagnosia Internetservices acquires Tyrolean MedEval
E-health specialist Diagnosia grows by taking over the drug data provider MedEval. Hospital-wide evidence-based decision making and IT-grounded drug safety will profit from MedEval’s long standing expertise and customer network.
BOKU EQ GmbH: Metabolomics at the core facility “cellular analysis” available
Top-notch metabolomics equipment and extensive know-how is available for your tasksin metabolomics and fluxomics. Profit from two tandem MS quadrupole systems and three accurate mass time-of-flight systems.
OncoQR ML's pancreatic cancer vaccine TYG100 induces clinically relevant immune response
In a preclinical trial in a highly relevant non-human primate (NHP) model the pancreatic cancer vaccine TYG100 was able to induce a strong and clinically relevant immune response within just 2 weeks after a single vaccination. No side-effects were observed.
Pfizer: 40 years of TBE production in Austria 
The active ingredients of some 10 million doses of the TBE vaccine are currentlyproduced in Austria annually. The vaccine protects against all known TBE-virus subtypes and has been developed by virologists at the University of Vienna 40 years ago.
The Antibody Lab and Conidia Bioscience start collaboration
he Antibody Lab will conduct feasibility and assay development work on Conidia’s specific proprietary antigens. Conidia Bioscience develops, manufactures, and sells fuel tests which detect microbial contamination within minutes.
Vetmeduni Vienna: When the immune system promotes tumor growth
The immune system plays an important role in the prevention of cancer. Researchers from the Vetmeduni Vienna have now discovered that NK cells can switch from eliminating cancerous cells to promoting tumor growth, with STAT5 acting as the key regulator.

Read more news at www.lisavienna.at.

LISAvienna NEWS and EVENTS

Web update:  Be invited to check out some impressions from Arab Health 2016. 
Mark your calendar

BioVaria 2016
Munich, Mai 17, 2016
Apply for the spin-off panel until March 25, 2016!

eHealth Summit Austria
Vienna, May 24-25, 2016
Contact Martin Mayer  to discuss participation at a reduced fee.

Delegation trip life sciences and biotechnology to China and Taiwan
Taipei, Shenzen, Guangzhou, Shanghai, August 29 – September 2, 2016
Discuss the event with Jürgen Fuchs and register until June 30, 2016!
Meet LISAvienna

BIO-Europe Spring® 2016
Stockholm, April 4-6, 2016

BioProcess International European Summit
Vienna, April 11-14, 2016

CMEF Spring 2016
Shanghai, 17.-20. April 2016

conhIT 2016
Berlin, 19.-21. April 2016

Austrian Showcase at Biotrinity 2016
London, April 25-27, 2016
Latest Publication

Our new Highlights newsletter provides insights into BoehringerIngelheim’s decision to invest half a billion euros in its biopharmaceutical production capacities in Vienna. Another 2.2 billion euros will be invested to bring medicine to the next level at the Medical University of Vienna and the Vienna General Hospital. We also feature clinical stage biotech products addressing infectious diseases and update you on electromechanical medical devices made in Vienna. News from numerous start-ups and research institutes will be presented as well.

More LISAvienna publications are available at www.lisavienna.at

FUNDING and SUPPORT Opportunities

aws: License.IP
aws supports you with locating and inlicensing of technologies to ensure faster availability of your development in the market. Up to 60 hours will be invested to identify technological solutions that meet your requirements. Inlicensing or using existing technological achievements can significantly push your development projects. Funding amounts to max. 50 % of eligible enforcement costs, with an upper limit of 200,000 euros.
Watch a video about this opportunity!

OPEN CALLS and DEADLINES to remember

April 14, 2016: H2020 - Cutoff date, dedicated SME Instrument, phase 2 (innovation projects)
April 26, 2016: FFG - COMET K-Projects
April 28, 2016: H2020 – Addressing the urgent research gaps against the Zika virus and other emerging threats in Latin America 
April 30, 2016: Vienna Business Agency – Location Initiative
May 13, 2016: CDG – CD Laboratories & JR-Centres

Register at bio@ffg.at for a free mailing service on European and other international funding initiatives in the life sciences.

EVENTS in Vienna

FFG: Projektentwicklung und Antragstellung in Horizon 2020

April 14, 2016, Haus der Forschung, Sensengasse 1, 1090 Vienna

austropharm – Fachmesse für pharmazeutische Produkte

April 21, 2016, Messe Wien & Congress Center, Messeplatz 1, 1020 Vienna

WIFI Wien: Fördertöpfe für Wiener Unternehmen

April 28, 2016, WIFI Wien, Währinger Gürtel 97, 1180 Vienna
For more events be invited to www.lisavienna.at.
Your news placed here: Vienna-based organizations are invited to e-mail news and press releases to news@LISAvienna.at to contribute to LISAvienna's digital and print media.

Stay updated: Follow us on Twitter, Xing and LinkedIn and recommend our e-newsletter to colleagues and friends.
 
Copyright © LISAvienna 2016, All rights reserved.

Our mailing address is: office@LISAvienna.at

LISAvienna is the joint life science platform operated by austria wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry of Science, Research and Economy and the city of Vienna, LISAvienna contributes to the advancement of life sciences in Vienna.

unsubscribe from this list  |  update subscription preferences